Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04000971 · ClinicalTrials.gov registry record · NA
Coordinated, Collaborative, Comprehensive, Family-based, Integrated, Technology-enabled Stroke Care
A NA study, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 1,196
- Enrollment target
NCT04000971: Completed NA study, sponsored by Vanderbilt University Medical Center.
NCT04000971 is a NA study that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 1,196 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (15% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04000971, a NA study, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,196 participants
- Enrollment target
Study Summary
Stroke is the 5th leading cause of death and the leading cause of adult disability in the United States (US). Stroke is a complex disease with multiple interacting risk factors (including genetic, high blood pressure and cholesterol, and lifestyle factors like smoking, diet, and exercise) that lead to initial and recurrent stroke. Up to 90% of stroke survivors have some functional deficit that impacts both physical and mental health.
Primary Outcome
59-item questionnaire to assess aspects of patient quality of life following stroke; includes 8 dimensions assessed on a 5-point Likert scale that are summed by domain. Scores range from 0-100, with higher scores indicating less difficulty.
Interventions
- OTHER Integrated Stroke Practice Unit
- OTHER Comprehensive or Primary Stroke Center
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,196 participants |
| Start Date | 2020-02-25 |
| Est. Completion | 2024-09-30 |
| Phase | NA |
What the finished NCT04000971 record still lists
NCT04000971 is an interventional study that assigns participants to a tested intervention. Its 1,196 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (15% lower).
The record links to 0 conditions, and to 2 interventions - of which Integrated Stroke Practice Unit is the first listed.
NCT04000971 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04000971 about?
NCT04000971 is a clinical study titled "Coordinated, Collaborative, Comprehensive, Family-based, Integrated, Technology-enabled Stroke Care". Stroke is the 5th leading cause of death and the leading cause of adult disability in the United States (US). Stroke is a complex disease with multiple interacting risk factors (including genetic, high blood pressure and cholesterol, and lifestyle factors like smoking, diet, and exercise) that lead ...
What is the current status of trial NCT04000971?
This trial is currently completed. It is a NA study. The enrollment target is 1,196 participants. The study started on 2020-02-25. Estimated completion is 2024-09-30.
What interventions are being tested in trial NCT04000971?
The interventions under investigation include: Integrated Stroke Practice Unit (OTHER), Comprehensive or Primary Stroke Center (OTHER).
Who is sponsoring clinical trial NCT04000971?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04000971's enrollment target sits among peer trials
1,196 89th of 2000 higher than 1,912 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07177339 · 1,196 participants · Phase 3
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- NCT00001987 · 1,200 participants
Genetic Studies of Insulin and Diabetes
- NCT00477100 · 1,200 participants
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
- NCT01209000 · 1,200 participants
Nephrotic Syndrome Study Network
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI